Essential cookies by default. The browser ID, load-time metrics and error replays only run if you choose "Accept all".
Head-to-head evidence comparison — which supplement is right for you?
Ciclopirox vs Efinaconazole: they're closely matched on evidence (5 vs 6.5/10); they're alternatives for stronger nails — the best pick depends on your goals. Take the 2-minute quiz for a pick tailored to your goals.
Ciclopirox and Efinaconazole are closely matched across evidence, studies, and safety.
Verdict
Too few graded studies
Top outcomes
Verdict
Too few graded studies
Top outcomes
Shared outcomes (2)
Outcomes where both Ciclopirox and Efinaconazole have evidence — compare verdict strength side-by-side.
A source-matched dose range is not available for this product and use.
If this treatment was prescribed for you, follow your prescriber’s directions. Do not change prescribed treatment because this page has no matched dose range.
Evening
Ciclopirox 8% nail lacquer
A source-matched dose range is not available for this product and use.
If this treatment was prescribed for you, follow your prescriber’s directions. Do not change prescribed treatment because this page has no matched dose range.
Evening
Efinaconazole 10% topical solution
long-term
long-term
long-term
long-term
long-term
long-term
long-term
long-term
Topical and device-based treatments for fungal infections of the toenails
Cochrane Database Syst Rev (2020) · Meta-Analysis · n=12501
56 studies, 12,501 participants. Only three were rated low risk of bias across all domains; the commonest high-risk domain was performance bias.
Therapies for onychomycosis: a systematic review and network meta-analysis of mycological cure
J Am Podiatr Med Assoc (2015) · Meta-Analysis
Network meta-analysis, needed because onychomycosis treatments are seldom compared head to head.
Ciclopirox 8% nail lacquer in the treatment of onychomycosis of the toenails in the United States
J Am Podiatr Med Assoc (2000) · Review
Reports the two pivotal US double-blind vehicle-controlled trials behind the FDA approval, alongside ten studies conducted worldwide.
Topical and device-based treatments for fungal infections of the toenails
Cochrane Database Syst Rev (2020) · Meta-Analysis · n=12501
56 studies, 12,501 participants across all topical and device-based treatments for toenail onychomycosis.
Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies
J Am Acad Dermatol (2013) · RCT · n=1655
Two identical multicentre randomised double-blind vehicle-controlled studies, 870 and 785 patients, randomised 3:1, once daily for 48 weeks with 4-week follow-up.
Efinaconazole 10% solution in the treatment of onychomycosis of the toenails
J Am Podiatr Med Assoc (2014) · Review · n=1655
Pooled report of the two pivotal trials across the United States, Canada and Japan, 1,655 patients.
Both Ciclopirox and Efinaconazole are closely matched — the best choice depends on your specific health goals.
For stronger nails, Efinaconazole has a higher relevance score (48 vs 45).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.